ESC Premium Access

Future treatments for lipoprotein(a).

Congress Session

About the speaker

Professor Stephen Nicholls

Monash Heart, Melbourne (Australia)
36 presentations
1 follower

3 more presentations in this session

Lipoprotein(a) and cardiovascular risk.

Speaker: Professor B. Nordestgaard (Copenhagen, DK)


Current treatment for elevated lipoprotein(a).

Speaker: Professor A. Goldberg (Saint Louis, US)


Lipoprotein(a): an emerging lipid risk factor – discussion.


Access the full session

Lipoprotein(a): an emerging lipid risk factor

Speakers: Professor S. Nicholls, Professor B. Nordestgaard, Professor A. Goldberg

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

Ablation or amiodarone for HFrEF patients with atrial fibrillation?

27 August 2021

ESC Premium Access

The long non-coding RNA Heat4 is upregulated in heart failure and decreases the immune response of non-classical monocytes

27 August 2021

ESC Premium Access

Cardiovascular protection by combination of the selective nonsteroidal MR antagonist finerenone and the SGLT2 inhibitor empagliflozin in a preclinical model of hypertension-induced end-organ damage

27 August 2021

This platform is supported by

logo Novo Nordisk